164 related articles for article (PubMed ID: 35394170)
21. Deep gray matter atrophy in neuromyelitis optica spectrum disorder and multiple sclerosis.
Hyun JW; Park G; Kwak K; Jo HJ; Joung A; Kim JH; Lee SH; Kim S; Lee JM; Kim SH; Kim HJ
Eur J Neurol; 2017 Feb; 24(2):437-445. PubMed ID: 28009104
[TBL] [Abstract][Full Text] [Related]
22. Impact of immunoablation and autologous hematopoietic stem cell transplantation on gray and white matter atrophy in multiple sclerosis.
Lee H; Nakamura K; Narayanan S; Brown R; Chen J; Atkins HL; Freedman MS; Arnold DL
Mult Scler; 2018 Jul; 24(8):1055-1066. PubMed ID: 28617152
[TBL] [Abstract][Full Text] [Related]
23. Deep gray matter changes in relapsing-remitting multiple sclerosis detected by multi-parametric, high-resolution magnetic resonance imaging (MRI).
Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
Eur Radiol; 2021 Feb; 31(2):706-715. PubMed ID: 32851443
[TBL] [Abstract][Full Text] [Related]
24. White matter tract network disruption explains reduced conscientiousness in multiple sclerosis.
Fuchs TA; Dwyer MG; Kuceyeski A; Choudhery S; Carolus K; Li X; Mallory M; Weinstock-Guttman B; Jakimovski D; Ramasamy D; Zivadinov R; Benedict RHB
Hum Brain Mapp; 2018 Sep; 39(9):3682-3690. PubMed ID: 29740964
[TBL] [Abstract][Full Text] [Related]
25. Automated segmentation of cerebral deep gray matter from MRI scans: effect of field strength on sensitivity and reliability.
Chu R; Hurwitz S; Tauhid S; Bakshi R
BMC Neurol; 2017 Sep; 17(1):172. PubMed ID: 28874119
[TBL] [Abstract][Full Text] [Related]
26. The sequence of structural, functional and cognitive changes in multiple sclerosis.
Dekker I; Schoonheim MM; Venkatraghavan V; Eijlers AJC; Brouwer I; Bron EE; Klein S; Wattjes MP; Wink AM; Geurts JJG; Uitdehaag BMJ; Oxtoby NP; Alexander DC; Vrenken H; Killestein J; Barkhof F; Wottschel V
Neuroimage Clin; 2021; 29():102550. PubMed ID: 33418173
[TBL] [Abstract][Full Text] [Related]
27. Diagnosis of depression in multiple sclerosis is predicted by frontal-parietal white matter tract disruption.
Ashton K; Fuchs TA; Oship D; Zivadinov R; Jakimovski D; Bergsland N; Ramasamy DP; Vaughn C; Weinstock-Guttman B; Benedict RHB; Dwyer MG
J Neurol; 2021 Jan; 268(1):169-177. PubMed ID: 32754832
[TBL] [Abstract][Full Text] [Related]
28. White Matter Tract Injury is Associated with Deep Gray Matter Iron Deposition in Multiple Sclerosis.
Bergsland N; Tavazzi E; Laganà MM; Baglio F; Cecconi P; Viotti S; Zivadinov R; Baselli G; Rovaris M
J Neuroimaging; 2017 Jan; 27(1):107-113. PubMed ID: 27239049
[TBL] [Abstract][Full Text] [Related]
29. Age-dependent cut-offs for pathological deep gray matter and thalamic volume loss using Jacobian integration.
Opfer R; Krüger J; Spies L; Hamann M; Wicki CA; Kitzler HH; Gocke C; Silva D; Schippling S
Neuroimage Clin; 2020; 28():102478. PubMed ID: 33269702
[TBL] [Abstract][Full Text] [Related]
30. Cognitive reserve, cognition, and regional brain damage in MS: A 2 -year longitudinal study.
Rocca MA; Riccitelli GC; Meani A; Pagani E; Del Sette P; Martinelli V; Comi G; Falini A; Filippi M
Mult Scler; 2019 Mar; 25(3):372-381. PubMed ID: 29303036
[TBL] [Abstract][Full Text] [Related]
31. Hereditary diffuse leukoencephalopathy with spheroids - a volumetric and radiological comparison with multiple sclerosis patients and healthy controls.
Granberg T; Hashim F; Andersen O; Sundal C; Karrenbauer VD
Eur J Neurol; 2016 Apr; 23(4):817-22. PubMed ID: 26756564
[TBL] [Abstract][Full Text] [Related]
32. Accurate GM atrophy quantification in MS using lesion-filling with co-registered 2D lesion masks.
Popescu V; Ran NC; Barkhof F; Chard DT; Wheeler-Kingshott CA; Vrenken H
Neuroimage Clin; 2014; 4():366-73. PubMed ID: 24567908
[TBL] [Abstract][Full Text] [Related]
33. Mild gray matter atrophy in patients with long-standing multiple sclerosis and favorable clinical course.
Cortese R; Battaglini M; Parodi F; Stromillo ML; Portaccio E; Razzolini L; Giorgio A; Sormani MP; Amato MP; De Stefano N
Mult Scler; 2022 Jan; 28(1):154-159. PubMed ID: 34100326
[TBL] [Abstract][Full Text] [Related]
34. The impact of deep grey matter volume on cognition in multiple sclerosis.
Lorefice L; Carta E; Frau J; Contu F; Casaglia E; Coghe G; Barracciu MA; Cocco E; Fenu G
Mult Scler Relat Disord; 2020 Oct; 45():102351. PubMed ID: 32731200
[TBL] [Abstract][Full Text] [Related]
35. Thalamic white matter in multiple sclerosis: A combined diffusion-tensor imaging and quantitative susceptibility mapping study.
Bergsland N; Schweser F; Dwyer MG; Weinstock-Guttman B; Benedict RHB; Zivadinov R
Hum Brain Mapp; 2018 Oct; 39(10):4007-4017. PubMed ID: 29923266
[TBL] [Abstract][Full Text] [Related]
36. Modeling the relationship among gray matter atrophy, abnormalities in connecting white matter, and cognitive performance in early multiple sclerosis.
Kuceyeski AF; Vargas W; Dayan M; Monohan E; Blackwell C; Raj A; Fujimoto K; Gauthier SA
AJNR Am J Neuroradiol; 2015 Apr; 36(4):702-9. PubMed ID: 25414004
[TBL] [Abstract][Full Text] [Related]
37. Clinically Isolated Syndrome Suggestive of Multiple Sclerosis: Dynamic Patterns of Gray and White Matter Changes-A 2-year MR Imaging Study.
Rocca MA; Preziosa P; Mesaros S; Pagani E; Dackovic J; Stosic-Opincal T; Drulovic J; Filippi M
Radiology; 2016 Mar; 278(3):841-53. PubMed ID: 26348234
[TBL] [Abstract][Full Text] [Related]
38. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.
Eijlers AJC; van Geest Q; Dekker I; Steenwijk MD; Meijer KA; Hulst HE; Barkhof F; Uitdehaag BMJ; Schoonheim MM; Geurts JJG
Brain; 2018 Sep; 141(9):2605-2618. PubMed ID: 30169585
[TBL] [Abstract][Full Text] [Related]
39. Label-fusion-segmentation and deformation-based shape analysis of deep gray matter in multiple sclerosis: the impact of thalamic subnuclei on disability.
Magon S; Chakravarty MM; Amann M; Weier K; Naegelin Y; Andelova M; Radue EW; Stippich C; Lerch JP; Kappos L; Sprenger T
Hum Brain Mapp; 2014 Aug; 35(8):4193-203. PubMed ID: 24510715
[TBL] [Abstract][Full Text] [Related]
40. Structural MRI substrates of cognitive impairment in neuromyelitis optica.
Liu Y; Fu Y; Schoonheim MM; Zhang N; Fan M; Su L; Shen Y; Yan Y; Yang L; Wang Q; Zhang N; Yu C; Barkhof F; Shi FD
Neurology; 2015 Oct; 85(17):1491-9. PubMed ID: 26423432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
